MedTrace Logo

Study to Evaluate the Safety of Nanoxel M Inj.

NCT04066335 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1498

Last updated 2019-12-18

No results posted yet for this study

Summary

Study to evaluate the safety of Nanoxel M inj. administration in patients.

Conditions

Sponsors & Collaborators

  • Samyang Biopharmaceuticals Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-18
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04066335 on ClinicalTrials.gov